ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹12,965 Cr | ₹12,668 Cr | ₹11,599 Cr | ₹10,634 Cr | ₹8,865 Cr |
What is the latest Revenue of ALKEM LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹12,965 Cr |
| Mar2025 | ₹12,668 Cr |
| Mar2024 | ₹11,599 Cr |
| Mar2023 | ₹10,634 Cr |
| Mar2022 | ₹8,865 Cr |
How is Revenue of ALKEM LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,965 Cr | 2.34 | |
| Mar2025 | ₹12,668 Cr | 9.21 | |
| Mar2024 | ₹11,599 Cr | 9.08 | |
| Mar2023 | ₹10,634 Cr | 19.96 | |
| Mar2022 | ₹8,865 Cr | - | |
Compare Revenue of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,971.8 Cr | 1.1% | -1.5% | -6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 1.1% |
-1.5% |
-6% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses